Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-17-038423)

Filing Details

Accession Number:: 0001209191-17-038423
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-07 19:02:26
Reporting Period:: 2017-06-05

Filing Date:: 2017-06-07
Accepted Time:: 2017-06-07 19:02:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1396814	Pacira Pharmaceuticals Inc.	PCRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1204788	M David Stack	C/O Pacira Pharmaceuticals, Inc. 5 Sylvan Way, Suite 300 Parsippany NJ 07054	Ceo And Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-06-05	4,311	$43.32	59,559	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	18,596	Indirect	By Stack Schroon Mohawk FLP
Common Stock	1,208	Indirect	By LCK Investment LLC

Footnotes

Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
Mr. Stack is the general partner of Stack Schroon Mohawk FLP. Mr. Stack and his wife are the owners of LCK Investment LLC.